Our Drug Design companies use rational approaches to create small molecule therapeutics for various diseases and conditions.
ComputChem is a software company building next generation platform solutions for in-silico covalent drug design and lead optimization.
covalent drug design and lead optimization.covalent drug design and lead optimization.
Rasio Therapeutics addresses unmet patient needs through modeling of novel/deep cell binding regions by designing molecules to fit those regions, enhancing treatment for cancer and other diseases.
SilcsBio provides computer-aided drug design solutions that dramatically accelerate and improve small molecule and biologic drug discovery pipelines.
Geminus Therapeutics is successfully developing novel Artemesinin (ART) drugs for treatment of acute myeloid leukemia (AML).